Related Experiment Video
Updated: Jun 26, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Non-adherence to medicines: not solved but solvable
1Division for Social Research in Medicines and Health, School of Pharmacy, University of Nottingham, Nottingham, UK. Rachel.elliott@nottingham.ac.uk
Journal of Health Services Research & Policy
|December 24, 2008
Summary
Patient medication non-adherence is a significant issue impacting health and costs. Improving adherence requires understanding patient beliefs, health system factors, and collaborative efforts, not just assuming compliance.
Area of Science:
- Health Behavior and Policy
- Patient Adherence Research
- Health Systems Analysis
Background:
- Medication non-adherence is prevalent, negatively affecting patient health outcomes and increasing healthcare system costs.
- A substantial portion of non-adherence is intentional, driven by patient beliefs and experiences with illness and treatments.
- Health system factors, including patient-practitioner relationships and access to care, significantly influence adherence.
Purpose of the Study:
- To synthesize evidence on the multifaceted drivers of medication non-adherence.
- To evaluate the effectiveness of current interventions and identify gaps in addressing adherence.
- To advocate for a collaborative approach involving patients, practitioners, researchers, and policymakers to improve medication adherence.
Main Methods:
- Review of extensive research literature on medication non-adherence.
- Analysis of patient-related factors, including beliefs and experiences.
- Examination of health system influences and policy impacts on adherence.
Main Results:
- Patient beliefs and experiences are key determinants of intentional non-adherence.
- Health system characteristics and policies (e.g., co-payments) significantly impact adherence rates.
- Current interventions often fail to achieve sustained behavior change due to insufficient integration of evidence and service delivery.
Conclusions:
- Effective strategies to improve medication adherence must address patient beliefs and health system factors.
- Policies should support, rather than assume, patient adherence to enhance effectiveness.
- Collaborative efforts among all stakeholders are essential for substantial improvements in medication adherence and health outcomes.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...